NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/26/2021
Back to search
Official data from USPTO
NUCARE PHARMACEUTICALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NUCARE PHARMACEUTICALS, INC.
ST13
US500000085230042Class
35, 39
Filing
85230042
Registration
4113938
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
11/28/2025
Trademark type
Word
Nice classes
35, 39
Filing date
01/31/2011
Registration date
03/20/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/26/2021
Last transaction
11/28/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/16/2000
First use in commerce
01/16/2001
Drawing code
4
Owner type
03
Owner location
ORANGE, CA
Examiner
GLASSER,CARYN
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NUCARE PHARMACEUTICALS, Inc.
Representatives
Amanda V. Dwight Burkhalter Kessler Clement & George LLP
Technical classification
Nice Classes
Class 35Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business services for others in the health care fieldnamely computerized on-line ordering to replenish drugs for pharmacies and medication dispensing machines; computerized database management in the field of pharmaceutical lot number and expiration dating; sales volume tracking; distributorship services featuring prepackaged pharmaceuticals and supplies
Class 39
Packaging pharmaceutical and health care products to the order and specification of others
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/26/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/26/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
03/22/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/20/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/09/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/09/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/09/2017
E815
TEAS SECTION 8 & 15 RECEIVED
10/17/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/20/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/20/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2012
PUBO
PUBLISHED FOR OPPOSITION
01/03/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/25/2011
ALIE
ASSIGNED TO LIE
11/25/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/03/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/03/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2011
GNRT
NON-FINAL ACTION E-MAILED
04/28/2011
CNRT
NON-FINAL ACTION WRITTEN
04/28/2011
DOCK
ASSIGNED TO EXAMINER
04/28/2011
MPMK
NOTICE OF PSEUDO MARK MAILED
02/04/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2011
NWAP
NEW APPLICATION ENTERED
02/03/2011
Continuous trademark protection
Get notified about every new filing that threatens NUCARE PHARMACEUTICALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.